source
- Psychedelic boom risks sidelining people of color despite new federal push and AbbVie's billion-dollar dealThe piece highlights that psychedelics are being praised for their therapeutic potential but still face scientific uncertainty and political debate. President Trump signed an executive order aimed…
- Seaport Therapeutics jumps over 20% on Nasdaq debut as former Karuna team outlines CNS research plansSeaport Therapeutics began trading on Nasdaq on May 1, 2026, ringing the opening bell. Its shares surged more than 20% on the first day. The company’s leadership, including the CEO and CSO, highli…